{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:04:55Z","timestamp":1789434295866,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhongshan Hospital, Fudan University","award":["2024ZSQN42"],"award-info":[{"award-number":["2024ZSQN42"]}]},{"name":"Zhongshan Hospital, Fudan University","award":["2024ZSFZ39"],"award-info":[{"award-number":["2024ZSFZ39"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200117"],"award-info":[{"award-number":["82200117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-026-00784-2","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:26:26Z","timestamp":1783441586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Th2 bias and T-cell exhaustion characterize the immunopathology of non-tuberculous mycobacterial pulmonary disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Tingting","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"784_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","volume":"11","author":"CN Ratnatunga","year":"2020","unstructured":"Ratnatunga, C. N. et al. The rise of non-tuberculosis mycobacterial lung disease. Front. Immunol. 11, 303 (2020).","journal-title":"Front. Immunol."},{"key":"784_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley, C. L. et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin. Infect. Dis. 71, 905 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"784_CR3","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-210927","volume":"72","author":"CS Haworth","year":"2017","unstructured":"Haworth, C. S. et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax 72, i1 (2017).","journal-title":"Thorax"},{"key":"784_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae421","volume":"79","author":"MH Nguyen","year":"2024","unstructured":"Nguyen, M. H. et al. Nontuberculous mycobacterial pulmonary disease: patients, principles, and prospects. Clin. Infect. Dis. 79, e27 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"784_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/cid\/ciae425","volume":"79","author":"MH Nguyen","year":"2024","unstructured":"Nguyen, M. H. et al. Executive summary: state-of-the-art review: nontuberculous mycobacterial pulmonary disease: patients, principles, and prospects. Clin. Infect. Dis. 79, 805\u2013806 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"784_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.chest.2024.03.024","volume":"166","author":"K Hyung","year":"2024","unstructured":"Hyung, K., Kim, S. A., Kim, J. Y., Kwak, N. & Yim, J. J. Rates and risk factors of progression in patients with nontuberculous mycobacterial pulmonary disease: secondary analysis of a prospective cohort study. Chest 166, 452\u2013460 (2024).","journal-title":"Chest"},{"key":"784_CR7","doi-asserted-by":"publisher","first-page":"1394220","DOI":"10.3389\/fmicb.2024.1394220","volume":"15","author":"LE Conyers","year":"2024","unstructured":"Conyers, L. E. & Saunders, B. M. Treatment for non-tuberculous mycobacteria: challenges and prospects. Front. Microbiol. 15, 1394220 (2024).","journal-title":"Front. Microbiol."},{"key":"784_CR8","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1016\/S1473-3099(21)00586-7","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange, C. et al. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet. Infect. Dis. 22, e178\u2013e190 (2022).","journal-title":"Lancet. Infect. Dis."},{"key":"784_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12931-022-02299-w","volume":"23","author":"R van der Laan","year":"2022","unstructured":"van der Laan, R., Snabilie, A. & Obradovic, M. Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery. Respir. Res. 23, 376 (2022).","journal-title":"Respir. Res."},{"key":"784_CR10","doi-asserted-by":"publisher","first-page":"112412","DOI":"10.1016\/j.intimp.2024.112412","volume":"137","author":"P Wang","year":"2024","unstructured":"Wang, P. et al. Single-cell transcriptomics of blood identified IFIT1(+) neutrophil subcluster expansion in NTM-PD patients. Int. Immunopharmacol. 137, 112412 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"784_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/thoraxjnl-2015-207983","volume":"71","author":"RA Floto","year":"2016","unstructured":"Floto, R. A. et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary. Thorax 71, 88\u201390 (2016).","journal-title":"Thorax"},{"key":"784_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/imr.13230","volume":"320","author":"ZJ Bernstein","year":"2023","unstructured":"Bernstein, Z. J., Shenoy, A., Chen, A., Heller, N. M. & Spangler, J. B. Engineering the IL-4\/IL-13 axis for targeted immune modulation. Immunol. Rev. 320, 29\u201357 (2023).","journal-title":"Immunol. Rev."},{"key":"784_CR13","doi-asserted-by":"publisher","first-page":"1276817","DOI":"10.3389\/fimmu.2023.1276817","volume":"14","author":"S Yandrapally","year":"2023","unstructured":"Yandrapally, S. et al. Mycobacterium tuberculosis EspR modulates Th1-Th2 shift by transcriptionally regulating IL-4, steering increased mycobacterial persistence and HIV propagation during co-infection. Front. Immunol. 14, 1276817 (2023).","journal-title":"Front. Immunol."},{"key":"784_CR14","doi-asserted-by":"publisher","first-page":"747799","DOI":"10.3389\/fimmu.2022.747799","volume":"13","author":"F Ahmad","year":"2022","unstructured":"Ahmad, F. et al. Macrophage: a cell with many faces and functions in tuberculosis. Front. Immunol. 13, 747799 (2022).","journal-title":"Front. Immunol."},{"key":"784_CR15","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/all.16108","volume":"79","author":"E Guttman-Yassky","year":"2024","unstructured":"Guttman-Yassky, E. et al. Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years. Allergy 79, 1560\u20131572 (2024).","journal-title":"Allergy"},{"key":"784_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41586-018-0439-x","volume":"560","author":"CR Roy","year":"2018","unstructured":"Roy, C. R. et al. A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes. Nature 560, 644\u2013648 (2018).","journal-title":"Nature"},{"key":"784_CR17","doi-asserted-by":"publisher","first-page":"927049","DOI":"10.3389\/fimmu.2022.927049","volume":"13","author":"A Gramegna","year":"2022","unstructured":"Gramegna, A. et al. Innate and adaptive lymphocytes in non-tuberculous mycobacteria lung disease: a review. Front. Immunol. 13, 927049 (2022).","journal-title":"Front. Immunol."},{"key":"784_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"784_CR19","doi-asserted-by":"publisher","first-page":"eaba7918","DOI":"10.1126\/sciimmunol.aba7918","volume":"5","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells. Sci. Immunol. 5, eaba7918 (2020).","journal-title":"Sci. Immunol."},{"key":"784_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jhep.2019.05.015","volume":"71","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. TOX promotes the exhaustion of antitumor CD8(+) T cells by preventing PD1 degradation in hepatocellular carcinoma. J. Hepatol. 71, 731\u2013741 (2019).","journal-title":"J. Hepatol."},{"key":"784_CR21","doi-asserted-by":"publisher","first-page":"102686","DOI":"10.1016\/j.ebiom.2020.102686","volume":"53","author":"Y Cai","year":"2020","unstructured":"Cai, Y. et al. Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis. Ebiomedicine 53, 102686 (2020).","journal-title":"Ebiomedicine"},{"key":"784_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","volume":"20","author":"P Chandra","year":"2022","unstructured":"Chandra, P., Grigsby, S. J. & Philips, J. A. Immune evasion and provocation by Mycobacterium tuberculosis. Nat. Rev. Microbiol. 20, 750\u2013766 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"784_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202000123","volume":"16","author":"M Orecchioni","year":"2020","unstructured":"Orecchioni, M. et al. Toward high-dimensional single-cell analysis of graphene oxide biological impact: tracking on immune cells by single-cell mass cytometry. Small 16, e2000123 (2020).","journal-title":"Small"},{"key":"784_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41584-019-0338-z","volume":"16","author":"FJ Hartmann","year":"2020","unstructured":"Hartmann, F. J. & Bendall, S. C. Immune monitoring using mass cytometry and related high-dimensional imaging approaches. Nat. Rev. Rheumatol. 16, 87\u201399 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"784_CR25","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1016\/j.cell.2023.08.033","volume":"186","author":"S Yu","year":"2023","unstructured":"Yu, S. et al. Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine. Cell 186, 4615\u20134631 (2023).","journal-title":"Cell"},{"key":"784_CR26","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41422-021-00562-1","volume":"31","author":"S Yu","year":"2021","unstructured":"Yu, S. et al. Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2(pos) subjects. Cell. Res. 31, 1148\u20131162 (2021).","journal-title":"Cell. Res."},{"key":"784_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga, R. et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer. Treat. Rev. 63, 40\u201347 (2018).","journal-title":"Cancer. Treat. Rev."},{"key":"784_CR28","doi-asserted-by":"publisher","first-page":"e00439-17","DOI":"10.1128\/JVI.00439-17","volume":"91","author":"M Fujino","year":"2017","unstructured":"Fujino, M. et al. Simian immunodeficiency virus targeting of CXCR3(+) CD4(+) T cells in secondary lymphoid organs is associated with robust CXCL10 expression in monocyte\/macrophage subsets. J. Virol. 91, e00439-17 (2017).","journal-title":"J. Virol."},{"key":"784_CR29","doi-asserted-by":"publisher","first-page":"1359555","DOI":"10.3389\/fimmu.2024.1359555","volume":"15","author":"W Ren","year":"2024","unstructured":"Ren, W. et al. Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection. Front. Immunol. 15, 1359555 (2024).","journal-title":"Front. Immunol."},{"key":"784_CR30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s10753-023-01791-9","volume":"46","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. CXCL9, 10, 11\/CXCR3 axis contributes to the progress of primary Sjogren\u2019s syndrome by activating GRK2 to promote T lymphocyte migration. Inflammation 46, 1047\u20131060 (2023).","journal-title":"Inflammation"},{"key":"784_CR31","doi-asserted-by":"publisher","first-page":"8032806","DOI":"10.1155\/2020\/8032806","volume":"2020","author":"M Xue","year":"2020","unstructured":"Xue, M. et al. Circulating Th1 and Th2 subset accumulation kinetics in septic patients with distinct infection sites: pulmonary versus nonpulmonary. Mediators. Inflamm. 2020, 8032806 (2020).","journal-title":"Mediators. Inflamm."},{"key":"784_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28506-2","volume":"13","author":"A Lovey","year":"2022","unstructured":"Lovey, A. et al. Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains. Nat. Commun. 13, 884 (2022).","journal-title":"Nat. Commun."},{"key":"784_CR33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","volume":"39","author":"MM Ravesloot-Chavez","year":"2021","unstructured":"Ravesloot-Chavez, M. M., Van Dis, E. & Stanley, S. A. The innate immune response to Mycobacterium tuberculosis infection. Annu. Rev. Immunol. 39, 611\u2013637 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"784_CR34","doi-asserted-by":"publisher","first-page":"1016038","DOI":"10.3389\/fimmu.2022.1016038","volume":"13","author":"AC Lindestam","year":"2022","unstructured":"Lindestam, A. C. et al. T-cell deficiency and hyperinflammatory monocyte responses associate with Mycobacterium avium complex lung disease. Front. Immunol. 13, 1016038 (2022).","journal-title":"Front. Immunol."},{"key":"784_CR35","doi-asserted-by":"publisher","first-page":"2073132","DOI":"10.1080\/19490976.2022.2073132","volume":"14","author":"YJ Kim","year":"2022","unstructured":"Kim, Y. J. et al. Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection. Gut. Microbes. 14, 2073132 (2022).","journal-title":"Gut. Microbes."},{"key":"784_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109941","volume":"9","author":"SY Kim","year":"2014","unstructured":"Kim, S. Y. et al. Importance of reciprocal balance of T cell immunity in Mycobacterium abscessus complex lung disease. PLoS ONE 9, e109941 (2014).","journal-title":"PLoS ONE"},{"key":"784_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787\u2013795 (2012).","journal-title":"J. Clin. Invest."},{"key":"784_CR38","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2019.03.028","volume":"27","author":"X Zhou","year":"2019","unstructured":"Zhou, X. et al. YAP aggravates inflammatory bowel disease by regulating M1\/M2 macrophage polarization and gut microbial homeostasis. Cell. Rep. 27, 1176\u20131189 (2019).","journal-title":"Cell. Rep."},{"key":"784_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/path.4399","volume":"234","author":"L Heitmann","year":"2014","unstructured":"Heitmann, L. et al. The IL-13\/IL-4Ralpha axis is involved in tuberculosis-associated pathology. J. Pathol. 234, 338\u2013350 (2014).","journal-title":"J. Pathol."},{"key":"784_CR40","doi-asserted-by":"publisher","first-page":"e74690","DOI":"10.7554\/eLife.74690","volume":"11","author":"M Lundahl","year":"2022","unstructured":"Lundahl, M. et al. Macrophage innate training induced by IL-4 and IL-13 activation enhances OXPHOS driven anti-mycobacterial responses. eLife 11, e74690 (2022).","journal-title":"eLife"},{"key":"784_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01234-1","volume":"19","author":"C Li","year":"2020","unstructured":"Li, C., Jiang, P., Wei, S., Xu, X. & Wang, J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol. Cancer. 19, 116 (2020).","journal-title":"Mol. Cancer."},{"key":"784_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.31083\/j.fbl2908301","volume":"29","author":"A Rubinstein","year":"2024","unstructured":"Rubinstein, A. et al. CXCR3-expressing T cells in infections and autoimmunity. Front. Biosci. 29, 301 (2024).","journal-title":"Front. Biosci."},{"key":"784_CR43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.coi.2015.03.004","volume":"34","author":"RM McEwen-Smith","year":"2015","unstructured":"McEwen-Smith, R. M., Salio, M. & Cerundolo, V. CD1d-dependent endogenous and exogenous lipid antigen presentation. Curr. Opin. Immunol. 34, 116\u2013125 (2015).","journal-title":"Curr. Opin. Immunol."},{"key":"784_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2008.07.011","volume":"29","author":"AK Savage","year":"2008","unstructured":"Savage, A. K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391\u2013403 (2008).","journal-title":"Immunity"},{"key":"784_CR45","doi-asserted-by":"publisher","first-page":"E10956","DOI":"10.1073\/pnas.1708252114","volume":"114","author":"A Chancellor","year":"2017","unstructured":"Chancellor, A. et al. CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains. Proc. Natl. Acad. Sci. USA 114, E10956\u2013E10964 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"784_CR46","doi-asserted-by":"publisher","first-page":"718350","DOI":"10.3389\/fcimb.2021.718350","volume":"11","author":"S Vogt","year":"2021","unstructured":"Vogt, S. & Mattner, J. NKT cells contribute to the control of microbial infections. Front. Cell. Infect. Microbiol. 11, 718350 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"784_CR47","doi-asserted-by":"publisher","first-page":"2102512","DOI":"10.1183\/13993003.02512-2021","volume":"60","author":"M Ahmed","year":"2022","unstructured":"Ahmed, M., Tezera, L. B., Elkington, P. T. & Leslie, A. J. The paradox of immune checkpoint inhibition re-activating tuberculosis. Eur. Respir. J. 60, 2102512 (2022).","journal-title":"Eur. Respir. J."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00784-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00784-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00784-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:02:03Z","timestamp":1789434123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00784-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1038\/s41540-026-00784-2","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"136"}}